Skip to content

HIV prevalence amongst IDUs in England and Wales at highest level since 1992

MSF calls for rapid registration of heat-stable Kaletra in low-income countries

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Treatment interruption arm of DART study halted

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

CD8 T-cells only kill a fifth of the HIV-infected CD4 T-cells

Prevention alongside treatment only way to contain HIV epidemic, scientific modelling finds

Proteins can help cells protect themselves from infection with HIV